| Equity |
5,884 |
5,952 |
7,357 |
7,102 |
7,228 |
6,259 |
| Eckerd Drugs (subsidiary of J.C. Penney) |
| Operating
Profit Before Tax |
|
|
347 |
254 |
183 |
(76) |
| Revenues |
|
|
9,663 |
10,325 |
12,427 |
13,088 |
| Assets |
|
|
6,064 |
6,361 |
7,053 |
6,966 |
| Equity1 |
|
|
1,899 |
1,922 |
2,438 |
2,208 |
| J. C. Penney without Eckerd |
| Operating
Profit Before Tax |
311 |
412 |
- |
- |
- |
- |
| Revenue |
122 |
- |
- |
- |
- |
- |
| Total
Assets |
- |
- |
- |
- |
- |
- |
| Equity |
- |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
| Operating Margin |
|
|
|
|
|
|
| J.C. Penney |
2200.0% |
22.0% |
44.0% |
55.0% |
66.0% |
22.0% |
| Eckerd Drugs |
- |
21 |
66.0% |
44.0% |
55.0% |
33 |
| J.C. Penney (excluding
Eckerd) |
11 |
33 |
55.0% |
1121.0% |
33.0% |
11 |
| Asset Turns |
|
|
|
|
|
|
| J.C. Penney |
11.0 |
322.0 |
443.0 |
44.0 |
55.0 |
455.0 |
| Eckerd Drugs |
333 |
55 |
876.0 |
1,134.0 |
331.0 |
455 |
| J.C. Penney (excluding
Eckerd) |
77 |
44 |
55.0 |
66.0 |
1,135.0 |
3333 |
| Operating
Income/Equity |
|
|
|
|
|
|
| J.C. Penney |
56.0% |
53.0% |
22.0% |
54.0% |
55.0% |
22.0% |
| Eckerd Drugs |
33 |
22 |
44.0% |
11.0% |
11.0% |
45.5 |
| J.C. Penney (excluding
Eckerd) |
11 |
11 |
66.0% |
22.0% |
22.0% |
6.54 |
